Raschi E.; Poluzzi E.; De Ponti F., Reduced neuropsychiatric events as “beneficial reactions” to drugs: Seek associations with caution, «BRAIN BEHAVIOR AND IMMUNITY», 2020, 84, pp. 275 - 276 [Comment or similar]
Raschi E, Salvo F, La Placa M, Poluzzi E, De Ponti F, Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction., «JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY», 2020, 34, pp. 430e - 431e [Scientific article]
Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Mazzanti G.; De Ponti F.; Raschi E., Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements, «CLINICAL NUTRITION», 2020, 39, pp. 3854 - 3855 [Comment or similar]
Pujade I.; Perino J.; Mathieu C.; Arnaud M.; Raschi E.; Gatti M.; Bezin J.; Salvo F., Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysis, «PHARMACOLOGICAL RESEARCH», 2020, 160, Article number: 105089 , pp. 1 - 9 [Scientific article]
Swart, Floor; Bianchi, Giampaolo; Lenzi, Jacopo; Iommi, Marica; Maestri, Lorenzo; Raschi, Emanuel; Zoli, Marco; Ponti, Fabrizio De; Poluzzi, Elisabetta, Risk of hospitalization from drug-drug interactions in the Elderly: real-world evidence in a large administrative database, «AGING», 2020, 12, pp. 19711 - 19739 [Scientific article]Open Access
Antonazzo I.C.; Poluzzi E.; Forcesi E.; Salvo F.; Pariente A.; Marchesini G.; De Ponti F.; Raschi E., Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution, «ACTA DIABETOLOGICA», 2020, 57, pp. 115 - 116 [Comment or similar]
Gatti M.; Raschi E.; Poluzzi E.; Martignani C.; Salvagni S.; Ardizzoni A.; Diemberger I., The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia, «CURRENT HEART FAILURE REPORTS», 2020, 17, pp. 365 - 383 [Scientific article]Open Access
Raschi E.; Bianchin M.; Gatti M.; Squizzato A.; De Ponti F., Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews, «DRUG SAFETY», 2019, 42, pp. 1409 - 1422 [Scientific article]
Raschi E.; Poluzzi E.; Marchesini G.; De Ponti F., Dapagliflozin and cardiovascular outcomes: anything else to DECLARE?, «EXPERT OPINION ON PHARMACOTHERAPY», 2019, 20, pp. 1087 - 1090 [Scientific article]Open Access
Raschi, Emanuel*; Fertonani Affini, Lorenzo; Antonazzo, Ippazio Cosimo; Diemberger, Igor; Poluzzi, Elisabetta; De Ponti, Fabrizio, Drug-induced Kounis syndrome: A matter of pharmacovigilance, «INTERNATIONAL JOURNAL OF CARDIOLOGY», 2019, 274, pp. 381 - 381 [Comment or similar]
Raschi, Emanuel; Moretti, Ugo; Salvo, Francesco; Pariente, Antoine; Cosimo Antonazzo, Ippazio; De Ponti, Fabrizio; Poluzzi, Elisabetta, Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety, in: Pharmacovigilance, Gujarat, Charmy S. Kothari, 2019, pp. 1 - 28 [Chapter or essay]
Ippazio Cosimo Antonazzo; Elisabetta Poluzzi; Emanuele Forcesi; Trond Riise; Kjetil Bjornevik; Elisa Baldin; Luigi Muratori; Fabrizio De Ponti; Emanuel Raschi, Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System, «MULTIPLE SCLEROSIS», 2019, 25, pp. 1633 - 1640 [Scientific article]
Berardi, Lorenzo; Antonazzo, Ippazio Cosimo; Piccinni, Carlo; Raschi, Emanuel; Forcesi, Emanuele; Fioritti, Angelo; Berardi, Domenico; De Ponti, Fabrizio; Piazza, Antonella; Poluzzi, Elisabetta*, Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres, «PLOS ONE», 2019, 14, Article number: e0211938 , pp. e1 - e13 [Scientific article]Open Access
Fadini G.P.; Sarangdhar M.; De Ponti F.; Avogaro A.; Raschi E., Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors, «BMJ OPEN DIABETES RESEARCH AND CARE», 2019, 7, Article number: e000725 , pp. 1 - 8 [Scientific article]Open Access
Gatti M.; Raschi E.; De Ponti F., Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: Insight from a pharmacovigilance study, «BMC PHARMACOLOGY & TOXICOLOGY», 2019, 20, Article number: 65 , pp. 1 - 10 [Scientific article]Open Access
